ATE505480T1 - Knochenpolypeptid-1 - Google Patents

Knochenpolypeptid-1

Info

Publication number
ATE505480T1
ATE505480T1 AT02805460T AT02805460T ATE505480T1 AT E505480 T1 ATE505480 T1 AT E505480T1 AT 02805460 T AT02805460 T AT 02805460T AT 02805460 T AT02805460 T AT 02805460T AT E505480 T1 ATE505480 T1 AT E505480T1
Authority
AT
Austria
Prior art keywords
bone
bone polypeptide
polypeptide
cdna
present
Prior art date
Application number
AT02805460T
Other languages
English (en)
Inventor
Christian Lanctot
Patrick Salois
Pierre Moffatt
Original Assignee
Enobia Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enobia Pharma Inc filed Critical Enobia Pharma Inc
Application granted granted Critical
Publication of ATE505480T1 publication Critical patent/ATE505480T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT02805460T 2001-12-20 2002-12-20 Knochenpolypeptid-1 ATE505480T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34122401P 2001-12-20 2001-12-20
PCT/IB2002/005778 WO2003054005A2 (en) 2001-12-20 2002-12-20 Bone polypeptide-1

Publications (1)

Publication Number Publication Date
ATE505480T1 true ATE505480T1 (de) 2011-04-15

Family

ID=23336705

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02805460T ATE505480T1 (de) 2001-12-20 2002-12-20 Knochenpolypeptid-1

Country Status (7)

Country Link
US (2) US7425531B2 (de)
EP (1) EP1458749B1 (de)
AT (1) ATE505480T1 (de)
AU (1) AU2002356392A1 (de)
CA (1) CA2469972A1 (de)
DE (1) DE60239763D1 (de)
WO (1) WO2003054005A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111234A1 (ja) * 2003-06-16 2004-12-23 Takeda Pharmaceutical Company Limited 新規蛋白質
HUE055861T2 (hu) 2004-04-21 2021-12-28 Alexion Pharma Inc Csontbejuttató konjugátumok és azok alkalmazási módszere fehérjék csonthoz kötéséhez
CN101426454B (zh) 2004-05-25 2012-06-06 泰科保健集团有限合伙公司 柔软的血管栓塞装置
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
JP4761812B2 (ja) * 2005-04-18 2011-08-31 武田薬品工業株式会社 マスクリン受容体およびその用途
US7470668B2 (en) * 2005-08-24 2008-12-30 Enobia Pharma Inc. Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof
WO2008038394A1 (en) 2006-09-30 2008-04-03 Takeda Pharmaceutical Company Limited Musclin receptor and use thereof
US9266939B2 (en) 2010-12-27 2016-02-23 Alexion Pharmaceuticals, Inc. Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
CA2967851C (en) 2014-12-05 2024-02-27 Alexion Pharmaceuticals, Inc. Treating seizure with recombinant alkaline phosphatase
AU2016211447B2 (en) 2015-01-28 2021-09-23 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
CN107709352A (zh) * 2015-05-29 2018-02-16 Igisu株式会社 环肽以及含有该环肽的药物、外用剂和化妆品
EP3337894A1 (de) 2015-08-17 2018-06-27 Alexion Pharmaceuticals, Inc. Herstellung von alkalischen phosphatasen
JP6868617B2 (ja) 2015-09-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド 低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
US11400140B2 (en) 2015-10-30 2022-08-02 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
KR20220162816A (ko) 2016-04-01 2022-12-08 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타아제로 근육 약화의 치료
WO2017173395A1 (en) 2016-04-01 2017-10-05 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
US10988744B2 (en) 2016-06-06 2021-04-27 Alexion Pharmaceuticals, Inc. Method of producing alkaline phosphatase
WO2018035420A1 (en) 2016-08-18 2018-02-22 Alexion Pharmaceuticals, Inc. Methods for treating tracheobronchomalacia
US20180194824A1 (en) 2016-12-14 2018-07-12 University Of Iowa Research Foundation Musclin peptides and methods of use thereof
JP2020512363A (ja) 2017-03-31 2020-04-23 アレクシオン ファーマシューティカルズ， インコーポレイテッド 成人及び青年における低ホスファターゼ症（ｈｐｐ）を治療する方法
US11065009B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US11065136B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
JP2021519590A (ja) 2018-03-30 2021-08-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド 糖タンパク質の製造
WO2020033867A2 (en) 2018-08-10 2020-02-13 Alexion Pharmaceuticals, Inc. Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
JP7796645B2 (ja) 2019-12-09 2026-01-09 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼポリペプチド及びその使用方法
CA3173631A1 (en) 2021-02-12 2022-08-18 Walter C. Voegtli Alkaline phosphatase polypeptides and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111234A1 (ja) 2003-06-16 2004-12-23 Takeda Pharmaceutical Company Limited 新規蛋白質
US7470668B2 (en) * 2005-08-24 2008-12-30 Enobia Pharma Inc. Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof

Also Published As

Publication number Publication date
EP1458749B1 (de) 2011-04-13
AU2002356392A8 (en) 2003-07-09
WO2003054005A3 (en) 2003-10-23
DE60239763D1 (de) 2011-05-26
WO2003054005A2 (en) 2003-07-03
EP1458749A2 (de) 2004-09-22
CA2469972A1 (en) 2003-07-03
US7425531B2 (en) 2008-09-16
US20030125258A1 (en) 2003-07-03
US20050143562A1 (en) 2005-06-30
AU2002356392A1 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
DE60239763D1 (de) Knochenpolypeptid-1
DE60224291D1 (de) System zur antikörperexpression und- synthese
DK1240325T3 (da) IL-17 og IL-17R homologe polypeptider og terapeutisk anvendelse deraf
MX362028B (es) Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
AR033978A1 (es) Molecula de anticuerpo con especificidad para factor de necrosis tumoral alfa humano y usos de las mismas
MX2012005864A (es) Proteinas de enlace al antígeno anti-orai 1 y usos de las mismas.
NZ603348A (en) Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
DE60044665D1 (de) Her2/neu fusionsproteine
TW200407425A (en) Human coagulation factor VII polypeptides
GB9924957D0 (en) Novel treatment
MX2009003636A (es) Nuevos peptidos para tratar y prevenir trastornos relacionados al sistema inmunitario, incluyendo el tratamiento y prevencion de la infeccion por modulacion de la inmunidad innata.
DE60118359D1 (de) Humanische pellino-polypeptide
DK1904529T3 (da) Anvendelse af Stefin A som et scaffoldprotein
FI971896A0 (fi) BMP-tyyppi II-reseptoria koodaava cDNA
EA200501711A1 (ru) Семейство секретируемых белков
MXPA04004564A (es) Genes que codifican receptores acoplados a proteinas g y metodos de uso de los mismos.
WO2003093419A3 (en) Preventing secondary lymphedema with vegf-d dna
SG161106A1 (en) Inhibitor proteins of a protease and use thereof
UA84831C2 (ru) Производные фактора коагуляции vii
WO2003057708A3 (en) Fusion proteins
ATE358682T1 (de) Klonierte rezeptoren des glukagon-ähnlichen peptids-2
ATE550351T1 (de) Vegf-d-mutanten und ihre verwendung
WO2003036264A3 (en) Treating diseases mediated by metalloprotease-shed proteins
WO2004029276A3 (en) Nucleic acids encoding a mammalian raptor polypeptide and uses therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties